Imaging of Facial Neuritis

Imaging of Facial Neuritis Using T2-weighted Gradient-echo Fast Imaging Employing Steady State Acquisition After Gadolinium Injection

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03543384

Enrollment

100

Registered

2018-06-01

Start date

2018-02-20

Completion date

2019-02-28

Last updated

2018-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Facial Neuritis

Keywords

facial neuritis, T2 weighted gradient-echo, fast imaging employing steady state acquisition (FIESTA-C), magnetic resonance imaging (MRI)

Brief summary

Improved means of positive diagnosis of facial neuritis, the leading cause of peripheral facial palsy

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 80 Years

Inclusion criteria

* Age 18-80 years * Subject giving their consent for their participation * Patients with neuritis facial (neuritis group) who benefited, between 2009 and 2016, from an MRI of the internal auditory ducts, with gadolinous product injection and on the MRI 3 Tesla * Patients with a perception deafness, without neuritis sign (control group) who also benefited from an MRI with gadolinous product injection on the MRI 3T with the same protocol.

Exclusion criteria

\- Refusal to participate in the study

Design outcomes

Primary

Measure	Time frame
Presence or absence of pathologic enhancement of the facial nerve on the symptomatological side of the T2 sequence (FIESTA-C)	1 hour after the realization of the MRI

Countries

France

Contacts

Primary ContactFrancis VEILLON, MD, PhD

Francis.veillon@chru-strasbourg.fr33 3 88 12 78 65

Backup ContactAïna VENKATASAMY, MD

aina.venkatasamy@chru-strasbourg.fr33 3 88 12 78 65

Outcome results